Sale!

CLDN14 Gene Deafness Autosomal Recessive Type 29 Genetic Test

Name: CLDN14 Gene Deafness Autosomal Recessive Type 29 Genetic Test
SKU: TEST-2714
Price: 4400 AED
Availability: InStock

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The CLDN14 gene plays a crucial role in the proper functioning of the inner ear, and mutations in this gene can lead to deafness autosomal recessive type 29 (DFNB29), a condition characterized by early-onset, non-syndromic sensorineural hearing loss. This form of hearing loss is inherited in an autosomal recessive manner, meaning that an individual must inherit two copies of the mutated gene, one from each parent, to be affected.

To diagnose this specific genetic cause of deafness, a genetic test focusing on the CLDN14 gene can be conducted. DNA Labs UAE offers this specialized test, providing a valuable tool for families seeking answers about their genetic predisposition to hearing loss. The test involves collecting a DNA sample, typically through a blood draw or a cheek swab, and analyzing it for mutations in the CLDN14 gene.

The cost of the CLDN14 gene deafness autosomal recessive type 29 genetic test at DNA Labs UAE is 4400 AED. This price may cover the cost of the sample collection, genetic analysis, and a comprehensive report detailing the findings. Such a test not only helps in confirming the diagnosis but also aids in family planning and understanding the risk of passing the condition to future generations.

Description

CLDN14 Gene Deafness Autosomal Recessive Type 29 Genetic Test

Test Name: CLDN14 Gene Deafness Autosomal Recessive Type 29 Genetic Test

Components: CLDN14 Gene Deafness Autosomal Recessive Type 29 Genetic Test

Price: 4400.0 AED

Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card

Report Delivery: 3 to 4 Weeks

Method: NGS Technology

Test Type: Ear Nose Throat Disorders

Doctor: ENT Doctor

Test Department: Genetics

Pre Test Information: Clinical History of Patient who is going for SLC52A3 Gene Brown-Vialetto-Van Laere syndrome 1 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with SLC52A3 Gene Brown-Vialetto-Van Laere syndrome 1 NGS Genetic DNA Test gene SLC52A10

Test Details: The CLDN14 gene is associated with deafness, specifically autosomal recessive type 29 (DFNB29). Autosomal recessive inheritance means that an individual must inherit two copies of the mutated gene (one from each parent) in order to develop the condition. NGS (Next-Generation Sequencing) genetic testing is a method used to analyze multiple genes simultaneously. It allows for a comprehensive assessment of the genetic variations within a specific gene or a panel of genes associated with a particular condition. In the case of CLDN14 gene deafness, an NGS genetic test would involve sequencing the CLDN14 gene to identify any mutations or variations that may be responsible for the development of deafness. This test can help in the diagnosis and genetic counseling of individuals with suspected DFNB29. It is important to note that genetic testing should be performed and interpreted by qualified healthcare professionals who specialize in genetics, as the results may have implications for the individual and their family members.

Test Name	CLDN14 Gene Deafness autosomal recessive type 29 Genetic Test
Components
Price	4400.0 AED
Sample Condition	Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery	3 to 4 Weeks
Method	NGS Technology
Test type	Ear Nose Throat Disorders
Doctor	ENT Doctor
Test Department:	Genetics
Pre Test Information	Clinical History of Patient who is going for SLC52A3 Gene Brown-Vialetto-Van Laere syndrome 1 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with SLC52A3 Gene Brown-Vialetto-Van Laere syndrome 1 NGS Genetic DNA Test gene SLC52A10
Test Details	The CLDN14 gene is associated with deafness, specifically autosomal recessive type 29 (DFNB29). Autosomal recessive inheritance means that an individual must inherit two copies of the mutated gene (one from each parent) in order to develop the condition. NGS (Next-Generation Sequencing) genetic testing is a method used to analyze multiple genes simultaneously. It allows for a comprehensive assessment of the genetic variations within a specific gene or a panel of genes associated with a particular condition. In the case of CLDN14 gene deafness, an NGS genetic test would involve sequencing the CLDN14 gene to identify any mutations or variations that may be responsible for the development of deafness. This test can help in the diagnosis and genetic counseling of individuals with suspected DFNB29. It is important to note that genetic testing should be performed and interpreted by qualified healthcare professionals who specialize in genetics, as the results may have implications for the individual and their family members.